Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| Takara Bio Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| Takara Bio Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| Takara Bio Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| Takara Bio Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| Takara Bio Inc., Medical Devices Deals, 2010 to YTD 2016 | 9 | 1 |
| Takara Bio Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Takara Bio Inc., Pharmaceuticals &Healthcare, Deal Details | 12 | 24 |
| Asset Purchase | 12 | 1 |
| Takara Bio Completes Acquisition Of HF10 Oncolytic Virus Business From M's Science | 12 | 1 |
| Partnerships | 13 | 1 |
| Clontech Labs Enters Into Technology Integration Agreement With Rubicon Genomics | 13 | 2 |
| Takara Bio Enters Into Co-Marketing Agreement With Exiqon For miRCURY LNA Products | 15 | 1 |
| Takara Bio Enters Into Research Agreement With TMUCIH | 16 | 1 |
| Takara Bio Forms Joint Venture With DSS Imagetech | 17 | 1 |
| NuGEN Enters Into Distribution Agreement With Takara | 18 | 1 |
| Takara Bio Enters Into Research Agreement With University of Pennsylvania | 19 | 1 |
| Licensing Agreements | 20 | 1 |
| MolMed and Takara Bio Terminate Licensing Agreement | 20 | 1 |
| Cellectis Enters into Licensing Agreement with Takara Bio for RetroNectin | 21 | 1 |
| Takara Bio Enters into Licensing Agreement with ViaCyte | 22 | 1 |
| Clontech Lab Enters into Licensing Agreement with Broad Institute for Crispr Gene Editing System | 23 | 1 |
| Takara Bio Expands Licensing Agreement With iPS Academia Japan | 24 | 1 |
| Takara Bio Enters Into Licensing Agreement With Cellular Dynamics International For RetroNectin | 25 | 1 |
| Eppendorf Enters Into Licensing Agreement With Takara Bio | 26 | 1 |
| ARIAD Pharma Enters Into Licensing Agreement With Clontech Labs | 27 | 2 |
| MDxHealth Enters Into Licensing Agreement With Takara Bio | 29 | 1 |
| Clontech Labs Enters Into Licensing Agreement With TET Systems Holding | 30 | 1 |
| Equity Offering | 31 | 1 |
| Takara Bio Prices Public Offering Of Common Stock For US$114.7 Million | 31 | 1 |
| Acquisition | 32 | 1 |
| Takara Bio to Acquire WaferGen Bio-Systems | 32 | 2 |
| Takara Bio Acquires Cellectis, Biotech Company | 34 | 2 |
| Takara Bio Inc. - Key Competitors | 36 | 1 |
| Key Employees | 37 | 1 |
| Locations And Subsidiaries | 38 | 1 |
| Head Office | 38 | 1 |
| Other Locations &Subsidiaries | 38 | 1 |
| Appendix | 39 | 1 |
| Methodology | 39 | 1 |
| About GlobalData | 39 | 1 |
| Contact Us | 39 | 1 |
| Disclaimer | 39 | 1 |